Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
other: read-across from constituent CrIII
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
publication
Title:
Studies on contact sensitivity to chromium in the guinea pig. The role of valence in the formation of the antigenic determinant.
Author:
Siegenthaler U, Laine A, Polak L
Year:
1983
Bibliographic source:
Journal of Investigative Dermatology 80 (1):44-47

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
GLP compliance:
not specified
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Existing data

Test material

1
Reference substance name:
Cr III
Molecular formula:
Cr III
IUPAC Name:
Cr III
Details on test material:
CrCl3.6H2O or CrCl3

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: chromium chloride (Merck, Darmstadt, FRG)
Sex:
male/female
Details on test animals and environmental conditions:
T hey weighed about 350- 400 g when sensitization was begun. The animals were bred at the Institute for Biochemical Research, Fii Uinsdorf, Switzerland. T hey were fed on peUet d iet supplemented
ad libitum with water containing vitamin C.

Study design: in vivo (non-LLNA)

Induction
Route:
intradermal
Vehicle:
not specified
Concentration / amount:
2 mg chromium chloride/l
Challenge
No.:
#1
Route:
epicutaneous, open
Vehicle:
not specified
Concentration / amount:
2 mg chromium chloride/l
No. of animals per dose:
10
Details on study design:
The sensit ization was done in the following manner: 5 injections of 0.2 ml each of emulsion containing 2 mg/ml of chromium chloride (Merck, Darmstadt, FRG) in FCA were given into the footpad and nape of the neck.
Animals were restimulated once a week by an intradermal injection of 25/-1g chromium chloride in 0.1 ml 0.15 M NaCl solu tion into the skin of the right fl ank. S imultaneously 0.02 ml of 0.5% chromium chloride solution in 1 % Triton X-100 were applied epicutaneously on the skin of the left flank. The boosting was continued weekly until a positive reaction to the hapten was observed. The animals were then challenged epicutaneously with both haptens and the skin inflammation evaluated 24 hr later according to an arbitrary scale: red, swollen = 2, red, contluent = 1, red spots = 0.5.
Challenge controls:
not applicable
Positive control substance(s):
not specified

Results and discussion

In vivo (non-LLNA)

Results
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
2 mg/L
No. with + reactions:
7
Total no. in group:
10
Clinical observations:
Seven out of 10 guinea-pigs sensitized and boosted with chromium chloride responded to an epicutaneous challenge with chromium chloride.
Remarks on result:
positive indication of skin sensitisation

Applicant's summary and conclusion

Interpretation of results:
Category 1 (skin sensitising) based on GHS criteria
Conclusions:
According to the results of the study, chromium trichloride can be considered to be a sensitizer to guinea pigs' skin.
Executive summary:

10 guinea pigs were exposed to 5 injections of 0.2 ml each of an emulsion containing either 2 mg chromium chloride/ml in Freund’s complete adjuvant (FCA) into the footpad and nape of the neck. The animals were restimulated once a week by intradermal injections of 25 µg of chromium trichloride. Simultaneously, 0.02 ml of 0.5% chromium trichloride in 1% Triton X-100 was applied epicutaneously to the skin of the opposite flank. The boosting was continued weekly until a positive reaction was observed. Four to six weeks after the positive skin reaction had emerged, the animals were challenged epicutaneously with both haptens, and skin inflammation was evaluated 24 h later. Seven out of 10 guinea-pigs sensitized and boosted with chromium trichloride responded to an epicutaneous challenge with chromium trichloride.